Clinical trial

PREPIC 2: Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption

NCT00457158 · Centre Hospitalier Universitaire de Saint Etienne, Other · Completed

Key facts

NCT number NCT00457158
Title PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption
Official title PREPIC 2 : Interruption of Inferior Vena Cava by a Retrievable Filter for the Prevention of Recurrent Pulmonary Embolism : a Randomised, Open Label Study
Acronym PREPIC2
Lead sponsor Centre Hospitalier Universitaire de Saint Etienne, Other
Collaborators Ministry of Health, France Fondation de France Fondation de l'Avenir ALN Implants Company
Status Completed
Phase Phase 4
Study type Interventional
Conditions Pulmonary Embolism, Venous Thrombosis
Intervention type Device
Interventions ALN optional filter
Enrollment 399
Start date Jul 1, 2006
Primary completion Nov 1, 2012
Completion Nov 1, 2012
First posted Apr 5, 2007
Last update posted Nov 27, 2012
Countries France

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies